Typically, when organisations speak of supply chain transparency, they focus on the last mile: the product journey from ...

The US Food and Drug Administration (FDA) has approved PTC Therapeutics’ Sephience (sepiapterin) to treat the rare metabolic ...

In exchange, Hengrui will receive $500m in upfront fees and will be eligible for approximately $12bn in development, ...

Bristol Myers Squibb (BMS) has announced that its CD19-directed CAR T cell therapy Breyanzi (lisocabtagene maraleucel) has ...

AbbVie has shared promising top-line results from a late-stage study of its JAK inhibitor Rinvoq (upadacitinib) in severe ...

Eli Lilly’s Alzheimer’s disease (AD) drug Kisunla (donanemab) has demonstrated a growing benefit over three years in patients with early symptomatic cases of the neurodegenerative disease, according ...

The Cannes Lions International Festival of Creativity is known for its topical breadth – and the smart pharma marketers who ...

Over the decades, I’ve probably worked with as many low performance brand teams as high performance ones. Typically, their ...

Eli Lilly’s GIP/GLP-1 dual receptor agonist Mounjaro (tirzepatide) has demonstrated cardiovascular protection in a late-stage ...

Cuttsy+Cuttsy is excited to announce the addition of three talented professionals to the team: Flo, an enthusiastic Account ...

Ipsen has received approval from the European Commission (EC) for its Exelixis-partnered Cabometyx (cabozantinib) in advanced ...